Clinical Trial Update: Clinical Trial of Safety and Efficacy of New Dosage Schedule for Dietressa Drug in Treatment of Obese Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update for a new dosage schedule of Dietressa in obesity shows completed status with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Dietressa

Snippet

Sponsor: Materia Medica Holding | Conditions: Obesity | Phase 3 | Status: COMPLETED | Results posted: 2021-08-26